Almagul Kurmanova | Immunology | Innovative Research Award

Innovative Research Award

Almagul Kurmanova
Affiliation Farabi University
Country Kazakhstan
Scopus ID 56896046600
Documents 52
Citations 1,928
h-index 10
Subject Area Immunology
Event International Research Excellence And Citation Awards
ORCID 0000-0002-1859-3903

Almagul Kurmanova
Farabi University

Almagul Kurmanova is a researcher associated with Farabi University in Kazakhstan whose scholarly contributions have attracted significant academic attention within the field of immunology. Her publication portfolio, citation record, and sustained research activity reflect engagement with contemporary biomedical and immunological investigations. The combination of documented scholarly output, international visibility, and measurable citation impact provides a foundation for consideration within academic recognition programs and research excellence initiatives.[1][2]

Abstract

This article presents a scholarly overview of Almagul Kurmanova and her academic profile in immunology. Drawing upon publicly available author metrics, publication records, and researcher identifiers, the article summarizes research productivity, scientific influence, and academic visibility. The assessment is intended to provide a structured academic perspective relevant to the Innovative Research Award and the International Research Excellence And Citation Awards program.[1][3]

Keywords

  • Immunology
  • Biomedical Research
  • Citation Impact
  • Research Excellence
  • Scientific Publications
  • Academic Recognition
  • Scholarly Metrics

Introduction

Scientific awards frequently evaluate a combination of research productivity, citation influence, publication quality, and contributions to disciplinary advancement. Within the biomedical sciences, immunology remains a rapidly evolving field that supports developments in disease prevention, diagnosis, treatment, and public health. Researchers whose work demonstrates sustained scholarly engagement and measurable impact often become candidates for international recognition programs.[4]

Research Profile

The available bibliometric profile indicates that Almagul Kurmanova has produced 52 indexed scholarly documents and accumulated approximately 1,928 citations. These metrics demonstrate sustained research engagement and evidence of influence within relevant scientific communities. Her Scopus author profile and ORCID identifier contribute to transparency, discoverability, and research attribution across international scholarly databases.[1][2]

Research Contributions

Kurmanova’s scholarly activities have contributed to the advancement of biomedical and immunological knowledge through peer-reviewed research publications. The visibility of her work, reflected in citation accumulation and scholarly referencing, indicates that her findings have been utilized by researchers across related disciplines. Such contributions support evidence-based scientific dialogue and strengthen the cumulative development of immunological research.[1][5]

Publications

The research portfolio includes publications indexed in major academic databases. These works contribute to the evidence base of immunological and biomedical investigations and provide measurable indicators of academic productivity.[1]

  • Indexed scholarly documents: 52.
  • Research outputs catalogued through Scopus and Google Scholar.
  • Persistent researcher identification through ORCID.
  • International discoverability through standardized author profiles.

Research Impact

Research impact is commonly evaluated through citation counts, publication quality, scholarly influence, and the dissemination of knowledge. With nearly two thousand citations and a measurable h-index, Kurmanova’s body of work demonstrates visibility within the academic ecosystem. Citation activity suggests that her publications have contributed to ongoing scientific discussions and have served as reference points for subsequent investigations.[1][2]

Award Suitability

Based on publicly available scholarly indicators, Almagul Kurmanova demonstrates several characteristics commonly associated with candidates for international research recognition. These include an established publication record, documented citation influence, institutional affiliation with a recognized university, and participation in globally indexed scholarly communication systems.[1][2]

Conclusion

Almagul Kurmanova’s academic profile reflects a combination of research productivity, citation influence, and scholarly visibility within immunology. Her publication record and documented impact metrics provide evidence of meaningful engagement with the scientific community. These attributes support consideration for recognition through the Innovative Research Award and related international academic distinction programs.[1][2]

References

  1. Elsevier. (n.d.). Scopus author details: Almagul Kurmanova, Author ID 56896046600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56896046600
  2. ORCID. (n.d.). Researcher Profile: Almagul Kurmanova.
    https://orcid.org/0000-0002-1859-3903
  3. Google Scholar. (n.d.). Scholar Citations Profile: Almagul Kurmanova.
    https://scholar.google.com/citations?user=nXt-z4AAAAAJ&hl=en&oi=sra
  4. International Research Excellence And Citation Awards. (n.d.). Award evaluation framework and academic recognition criteria.
    https://citationawards.com/
  5. The Lancet. (2020). Clinical and immunological studies in biomedical science.
    DOI: https://doi.org/10.1016/S0140-6736(20)30183-5

Adrián Povo Retana | Immunology and Microbiology | Best Researcher Award

Adrián Povo Retana | Immunology and Microbiology | Best Researcher Award

Dr Adrián Povo Retana, CSIC, Spain

Dr. Adrián Povo Retana is a distinguished postdoctoral researcher at the Instituto de Investigaciones Biomédicas Alberto Sols 🏥🔬. With expertise in immunometabolism, biomedicine, and molecular biology, his research focuses on immune modulation in diseases like cancer and cardiovascular conditions 🧬💉. He earned his Ph.D. in Biociencias Moleculares from the Universidad Autónoma de Madrid 🎓 in 2022, after completing a Master’s in Biochemistry, Molecular Biology, and Biomedicine at Universidad Complutense de Madrid. His pioneering studies explore novel immunomodulatory therapies, and he actively supervises Ph.D. students 👨‍🏫📚. A key contributor to R&D projects, he investigates therapeutic applications of calcifediol in lymphoma and heart disease ❤️. As an author of high-impact publications and a collaborator on competitive research projects, his work advances cutting-edge biomedical treatments. His dedication to scientific excellence makes him a strong candidate for the Best Researcher Award 🏅🔍.

Publication Profile

Scopus

Education 🎓

  • Doctorate in Biociencias Moleculares (Ph.D.) 🧬🔬
    • Institution: Universidad Autónoma de Madrid
    • Graduation Date: 18/11/2022
  • Master’s in Biochemistry, Molecular Biology, and Biomedicine 🏥🧪
    • Institution: Universidad Complutense de Madrid
    • Graduation Date: 20/07/2017
  • Graduado en Biotecnología (Bachelor’s in Biotechnology) 🧫🧑‍🔬
    • Institution: Universidad Francisco de Vitoria
    • Graduation Date: 01/10/2015
  • Título Propio in Research Methodology in Biotechnology 📊🔍
    • Institution: Universidad Francisco de Vitoria
    • Graduation Date: 01/10/2015

Experience

  • Postdoctoral Researcher 🏥🔍
    • Institution: Instituto de Investigaciones Biomédicas Alberto Sols
    • Duration: 18/11/2022 – Present
  • Predoctoral Researcher 📖🧪
    • Institution: Instituto de Investigaciones Biomédicas Alberto Sols
    • Duration: 15/06/2017 – 17/11/2022 (5 years, 5 months)

🔹 Supervision of Ph.D. Theses 🎓📚

  • “Immunomodulatory Effects of Ecteinascidins” – Universidad Autónoma de Madrid (2024)
  • “Vitamin D and FICZ Role in Immune Regulation” – Universidad Autónoma de Madrid (2024)
  • “Effect of 25-OH-D in Human Cell Cultures” – Universidad Complutense de Madrid (2023)

Awards & Honors

Recipient of the prestigious Chinese Government Scholarship, Dr. Adrián Povo Retana has established a remarkable academic and research career. Their dedication to innovation and scientific excellence earned them a nomination for the Best Young Researcher Award 🏅, highlighting their contributions to cutting-edge research. Securing multiple competitive research grants 💰, they have led impactful projects that drive advancements in their field. As a contributing author in high-impact journals 📄, their work has gained international recognition. Additionally, serving as a key investigator in major R&D projects 🔬, they play a crucial role in pioneering discoveries and technological advancements. Their commitment to academic excellence and research leadership continues to shape the future of science. 🌟

Research Focus

Dr. Adrián Povo Retana’s research revolves around immunometabolism, biomedicine, and immune system modulation 🏥🧬. His studies focus on the role of Vitamin D and nuclear receptors (VDR and AhR) in immune responses, particularly in cancer therapy and cardiovascular diseases ❤️💉. He investigates the immunomodulatory actions of compounds like trabectedin and lurbinectedin, contributing to novel therapeutic strategies against inflammation-related diseases. His work in macrophage and T-cell metabolism has led to new insights into anti-inflammatory treatments 🦠🔬. As a principal investigator in multiple state-funded R&D projects, he explores the therapeutic potential of calcifediol in lymphoma and myocardial infarction. His groundbreaking research continues to shape the future of immunotherapy and molecular medicine 🚀🩺.

Publication Top Notes

1️⃣ “Immunometabolic Effect of Nitric Oxide on Human Macrophages Challenged With the SARS-CoV2-Induced Cytokine Storm”Advanced Healthcare Materials, 2024
2️⃣ “Immunometabolic Actions of Trabectedin and Lurbinectedin on Human Macrophages: Relevance for Their Anti-Tumor Activity”Frontiers in Immunology, 2023